We're dedicated to providing safe and effective medicines, alongside services and support for healthy outcomes. This involves superior science, creativity, and collaboration with stakeholders at all levels. As a leading pharma company in the U.S., we focus on devastating diseases and complex medical challenges across six specific therapeutic areas: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
The grant program aims to fund programs and initiatives that improve patient access to treatment and services, advance health equity, and strengthen frontline health workforces within specified therapeutic areas. It supports disease awareness efforts, patient empowerment and advocacy, and linkages to care, with a preference for programs focused on health system improvement with measurable outcomes over fundraising activities. Specifically, in the field of Neuroscience, it funds recovery-focused programs, early intervention, access and continuity of care, relapse prevention, addressing healthcare disparities and stigma, crisis intervention, and education and programs related to mental health and the criminal justice system. Target beneficiaries may include patients, caregivers/families, peers, policy makers, community leaders, or the broader community.